Cargando…

Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?

BACKGROUND: The debate on the best treatment strategy for atrial fibrillation (AF) has expanded following the introduction of the so-called “hybrid procedure” that combines minimally invasive epicardial ablation with endocardial catheter ablation. However, the advantage of the hybrid approach over c...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasso, Giuseppe, Lorusso, Roberto, Moscarelli, Marco, De Martino, Giuseppe, Dell’Aquila, Angelo M., Motekallemi, Arash, Di Bari, Nicola, Condello, Ignazio, Mastroroberto, Pasquale, Santarpino, Giuseppe, Speziale, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236186/
https://www.ncbi.nlm.nih.gov/pubmed/34174911
http://dx.doi.org/10.1186/s13019-021-01565-0
_version_ 1783714486291529728
author Nasso, Giuseppe
Lorusso, Roberto
Moscarelli, Marco
De Martino, Giuseppe
Dell’Aquila, Angelo M.
Motekallemi, Arash
Di Bari, Nicola
Condello, Ignazio
Mastroroberto, Pasquale
Santarpino, Giuseppe
Speziale, Giuseppe
author_facet Nasso, Giuseppe
Lorusso, Roberto
Moscarelli, Marco
De Martino, Giuseppe
Dell’Aquila, Angelo M.
Motekallemi, Arash
Di Bari, Nicola
Condello, Ignazio
Mastroroberto, Pasquale
Santarpino, Giuseppe
Speziale, Giuseppe
author_sort Nasso, Giuseppe
collection PubMed
description BACKGROUND: The debate on the best treatment strategy for atrial fibrillation (AF) has expanded following the introduction of the so-called “hybrid procedure” that combines minimally invasive epicardial ablation with endocardial catheter ablation. However, the advantage of the hybrid approach over conventional epicardial ablation remains to be established. METHODS: From June 2008 to December 2020, 609 surgical AF ablation procedures through a right minithoracotomy were performed at our institution. From 2008 to 2011, a unipolar radiofrequency (RF) device was used, whereas from 2011 to 2020 a bipolar RF device was used. In addition, between September 2016 and April 2017, 60 patients underwent endocardial completion of epicardial linear ablation. In 30 of these latter patients, surgical isolation of the Bachmann’s bundle (BB) was also performed. Starting from 2021, surviving patients at follow-up were asked to undergo electrocardiographic evaluation and left ventricular function assessment and to complete a questionnaire addressing quality of life and predisposing factors for recurrent AF. RESULTS: The ablation procedure was completed in all patients. Upon discharge, 30 (4.9%) patients showed recurrence of AF, whereas the remaining patients (95.1%) were in sinus rhythm. All patients in whom a hybrid approach was used either with or without BB ablation were discharged in sinus rhythm. After a mean follow-up of 74 months, 122 (20%) patients developed recurrent AF, including 19.9% in whom a unipolar RF device was used, 21% in whom a bipolar RF device was used, 23% who had undergone a hybrid procedure without BB ablation and 3.3% who had undergone a hybrid procedure with BB ablation. On multivariate analysis, reduced left ventricular ejection fraction, worsening of European Heart Rhythm Association symptom class, and cognitive impairment or depression during follow-up were found to be significantly associated with AF recurrence. CONCLUSIONS: Surgical AF ablation through a right minithoracotomy is safe and may allow the creation of additional linear lesions, particularly in the BB. The placement of adjunctive linear lesions in the setting of a hybrid procedure can be more effective in reducing the risk for AF recurrence than isolated surgical ablation or hybrid ablation without the addition of further linear lesions, with no incremental risk to the patient.
format Online
Article
Text
id pubmed-8236186
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82361862021-06-28 Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation? Nasso, Giuseppe Lorusso, Roberto Moscarelli, Marco De Martino, Giuseppe Dell’Aquila, Angelo M. Motekallemi, Arash Di Bari, Nicola Condello, Ignazio Mastroroberto, Pasquale Santarpino, Giuseppe Speziale, Giuseppe J Cardiothorac Surg Research Article BACKGROUND: The debate on the best treatment strategy for atrial fibrillation (AF) has expanded following the introduction of the so-called “hybrid procedure” that combines minimally invasive epicardial ablation with endocardial catheter ablation. However, the advantage of the hybrid approach over conventional epicardial ablation remains to be established. METHODS: From June 2008 to December 2020, 609 surgical AF ablation procedures through a right minithoracotomy were performed at our institution. From 2008 to 2011, a unipolar radiofrequency (RF) device was used, whereas from 2011 to 2020 a bipolar RF device was used. In addition, between September 2016 and April 2017, 60 patients underwent endocardial completion of epicardial linear ablation. In 30 of these latter patients, surgical isolation of the Bachmann’s bundle (BB) was also performed. Starting from 2021, surviving patients at follow-up were asked to undergo electrocardiographic evaluation and left ventricular function assessment and to complete a questionnaire addressing quality of life and predisposing factors for recurrent AF. RESULTS: The ablation procedure was completed in all patients. Upon discharge, 30 (4.9%) patients showed recurrence of AF, whereas the remaining patients (95.1%) were in sinus rhythm. All patients in whom a hybrid approach was used either with or without BB ablation were discharged in sinus rhythm. After a mean follow-up of 74 months, 122 (20%) patients developed recurrent AF, including 19.9% in whom a unipolar RF device was used, 21% in whom a bipolar RF device was used, 23% who had undergone a hybrid procedure without BB ablation and 3.3% who had undergone a hybrid procedure with BB ablation. On multivariate analysis, reduced left ventricular ejection fraction, worsening of European Heart Rhythm Association symptom class, and cognitive impairment or depression during follow-up were found to be significantly associated with AF recurrence. CONCLUSIONS: Surgical AF ablation through a right minithoracotomy is safe and may allow the creation of additional linear lesions, particularly in the BB. The placement of adjunctive linear lesions in the setting of a hybrid procedure can be more effective in reducing the risk for AF recurrence than isolated surgical ablation or hybrid ablation without the addition of further linear lesions, with no incremental risk to the patient. BioMed Central 2021-06-26 /pmc/articles/PMC8236186/ /pubmed/34174911 http://dx.doi.org/10.1186/s13019-021-01565-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Nasso, Giuseppe
Lorusso, Roberto
Moscarelli, Marco
De Martino, Giuseppe
Dell’Aquila, Angelo M.
Motekallemi, Arash
Di Bari, Nicola
Condello, Ignazio
Mastroroberto, Pasquale
Santarpino, Giuseppe
Speziale, Giuseppe
Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
title Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
title_full Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
title_fullStr Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
title_full_unstemmed Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
title_short Catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
title_sort catheter, surgical, or hybrid procedure: what future for atrial fibrillation ablation?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236186/
https://www.ncbi.nlm.nih.gov/pubmed/34174911
http://dx.doi.org/10.1186/s13019-021-01565-0
work_keys_str_mv AT nassogiuseppe cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT lorussoroberto cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT moscarellimarco cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT demartinogiuseppe cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT dellaquilaangelom cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT motekallemiarash cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT dibarinicola cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT condelloignazio cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT mastrorobertopasquale cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT santarpinogiuseppe cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation
AT spezialegiuseppe cathetersurgicalorhybridprocedurewhatfutureforatrialfibrillationablation